Cintia Piccina serves as Executive at Adaptimmune Therapeutics PLC, where they oversee executive responsibilities. Since joining the company, Cintia Piccina has executed 4 insider transactions totaling $82.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 18, 2024 involved selling 24,531 shares valued at $22.8K.
Cintia Piccina currently holds 38,293 shares of Adaptimmune Therapeutics PLC (ADAP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cintia Piccina has been a net seller of ADAP stock. They have purchased $0 and sold $82.3K worth of shares.
Cintia Piccina's most recent insider trade was on Jun 18, 2024, when they sold 24,531 shares at $0.93 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 31, 2023 | ADAP | $22.2K | Sale | 11,890 | $1.87 | Discretionary |
| Aug 1, 2022 | ADAP | $37.2K | Sale | 21,040 | $1.77 | Discretionary |